217 related articles for article (PubMed ID: 25798629)
1. Modeling Parkinson's disease falls associated with brainstem cholinergic systems decline.
Kucinski A; Sarter M
Behav Neurosci; 2015 Apr; 129(2):96-104. PubMed ID: 25798629
[TBL] [Abstract][Full Text] [Related]
2. Modeling falls in Parkinson's disease: Slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss.
Kucinski A; Albin RL; Lustig C; Sarter M
Behav Brain Res; 2015 Apr; 282():155-64. PubMed ID: 25595423
[TBL] [Abstract][Full Text] [Related]
3. Reduction of falls in a rat model of PD falls by the M1 PAM TAK-071.
Kucinski A; Sarter M
Psychopharmacology (Berl); 2021 Jul; 238(7):1953-1964. PubMed ID: 33735392
[TBL] [Abstract][Full Text] [Related]
4. Complex Movement Control in a Rat Model of Parkinsonian Falls: Bidirectional Control by Striatal Cholinergic Interneurons.
Avila C; Kucinski A; Sarter M
J Neurosci; 2020 Jul; 40(31):6049-6067. PubMed ID: 32554512
[TBL] [Abstract][Full Text] [Related]
5. The anterior and posterior pedunculopontine tegmental nucleus are involved in behavior and neuronal activity of the cuneiform and entopeduncular nuclei.
Jin X; Schwabe K; Krauss JK; Alam M
Neuroscience; 2016 May; 322():39-53. PubMed ID: 26880033
[TBL] [Abstract][Full Text] [Related]
6. Low-frequency stimulation of the pedunculopontine nucleus affects gait and the neurotransmitter level in the ventrolateral thalamic nucleus in 6-OHDA Parkinsonian rats.
Wen P; Li M; Xiao H; Ding R; Chen H; Chang J; Zhou M; Yang Y; Wang J; Zheng W; Zhang W
Neurosci Lett; 2015 Jul; 600():62-8. PubMed ID: 26054938
[TBL] [Abstract][Full Text] [Related]
7. An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.
Pienaar IS; Harrison IF; Elson JL; Bury A; Woll P; Simon AK; Dexter DT
Brain Struct Funct; 2015 Jan; 220(1):479-500. PubMed ID: 24292256
[TBL] [Abstract][Full Text] [Related]
8. Selective cholinergic depletion of pedunculopontine tegmental nucleus aggravates freezing of gait in parkinsonian rats.
Xiao H; Li M; Cai J; Li N; Zhou M; Wen P; Xie Z; Wang Q; Chang J; Zhang W
Neurosci Lett; 2017 Oct; 659():92-98. PubMed ID: 28803956
[TBL] [Abstract][Full Text] [Related]
9. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
Bensaid M; Michel PP; Clark SD; Hirsch EC; François C
Exp Neurol; 2016 Jan; 275 Pt 1():209-19. PubMed ID: 26571193
[TBL] [Abstract][Full Text] [Related]
10. Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats.
Chambers NE; Coyle M; Sergio J; Lanza K; Saito C; Topping B; Clark SD; Bishop C
Eur J Neurosci; 2021 Apr; 53(8):2835-2847. PubMed ID: 33426708
[TBL] [Abstract][Full Text] [Related]
11. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.
Müller ML; Albin RL; Kotagal V; Koeppe RA; Scott PJ; Frey KA; Bohnen NI
Brain; 2013 Nov; 136(Pt 11):3282-9. PubMed ID: 24056537
[TBL] [Abstract][Full Text] [Related]
12. Modeling fall propensity in Parkinson's disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation.
Kucinski A; Paolone G; Bradshaw M; Albin RL; Sarter M
J Neurosci; 2013 Oct; 33(42):16522-39. PubMed ID: 24133257
[TBL] [Abstract][Full Text] [Related]
13. Reducing falls in Parkinson's disease: interactions between donepezil and the 5-HT
Kucinski A; de Jong IE; Sarter M
Eur J Neurosci; 2017 Jan; 45(2):217-231. PubMed ID: 27469080
[TBL] [Abstract][Full Text] [Related]
14. Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease.
Koshy Cherian A; Kucinski A; Wu R; de Jong IEM; Sarter M
Psychopharmacology (Berl); 2019 Jun; 236(6):1701-1715. PubMed ID: 30607479
[TBL] [Abstract][Full Text] [Related]
15. Dichotomy between motor and cognitive functions of midbrain cholinergic neurons.
Gut NK; Mena-Segovia J
Neurobiol Dis; 2019 Aug; 128():59-66. PubMed ID: 30213733
[TBL] [Abstract][Full Text] [Related]
16. Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson's Disease.
Elson JL; Kochaj R; Reynolds R; Pienaar IS
Neurotox Res; 2018 Jul; 34(1):16-31. PubMed ID: 29218504
[TBL] [Abstract][Full Text] [Related]
17. Pedunculopontine Nucleus Microstructure Predicts Postural and Gait Symptoms in Parkinson's Disease.
Craig CE; Jenkinson NJ; Brittain JS; Grothe MJ; Rochester L; Silverdale M; Alho ATDL; Alho EJL; Holmes PS; Ray NJ
Mov Disord; 2020 Jul; 35(7):1199-1207. PubMed ID: 32400071
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease.
Karachi C; Grabli D; Bernard FA; Tandé D; Wattiez N; Belaid H; Bardinet E; Prigent A; Nothacker HP; Hunot S; Hartmann A; Lehéricy S; Hirsch EC; François C
J Clin Invest; 2010 Aug; 120(8):2745-54. PubMed ID: 20628197
[TBL] [Abstract][Full Text] [Related]
19. Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems.
Grabli D; Karachi C; Folgoas E; Monfort M; Tande D; Clark S; Civelli O; Hirsch EC; François C
J Neurosci; 2013 Jul; 33(29):11986-93. PubMed ID: 23864685
[TBL] [Abstract][Full Text] [Related]
20. Unilateral pedunculopontine stimulation improves falls in Parkinson's disease.
Moro E; Hamani C; Poon YY; Al-Khairallah T; Dostrovsky JO; Hutchison WD; Lozano AM
Brain; 2010 Jan; 133(Pt 1):215-24. PubMed ID: 19846583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
